鼻内镜下经鼻入路在巨大垂体腺瘤多模式治疗中的作用:病例报告及文献综述
The Role of Endoscopic Endonasal Approach in the Multimodal Management of Giant Pituitary Adenoma: Case Report and Literature Review.
作者信息
Chibbaro Salvatore, Ganau Mario, Gubian Arthur, Scibilia Antonino, Todeschi Julien, Riehm Sophie, Moliere Sebastien, Debry Christian, Goichot Bernard, Proust Francois, Cebula Helene
机构信息
Department of Neurosurgery, Hautepierre University Hospital, Strasbourg, France.
Department of Neuro-Radiology, Hautepierre University Hospital, Strasbourg, France.
出版信息
Asian J Neurosurg. 2018 Jul-Sep;13(3):888-892. doi: 10.4103/ajns.AJNS_97_18.
Giant pituitary adenomas (GPAs) are defined as pituitary lesions larger than 40 mm of diameter. Surgical resection remains the gold standard to decompress the optic apparatus, reduce lesion load, and preserve hormonal function. The endoscopic endonasal approach (EEA) has been increasingly used for the treatment of pituitary adenomas and skull base tumors due to the wide angle of view and exposure. Through the description of an exemplificative case of EEA resection of a nonsecreting GPA in the setting of a multimodal treatment, the authors discuss the advantages and disadvantages of this management strategy and provide a detailed review of the literature.
巨大垂体腺瘤(GPA)被定义为直径大于40毫米的垂体病变。手术切除仍然是对视神经装置进行减压、减少病变负荷并保留激素功能的金标准。由于视野开阔和暴露充分,鼻内镜经鼻入路(EEA)越来越多地用于治疗垂体腺瘤和颅底肿瘤。通过描述在多模式治疗背景下经EEA切除无分泌功能GPA的一个典型病例,作者讨论了这种管理策略的优缺点,并对文献进行了详细综述。
相似文献
World Neurosurg. 2018-6
Neurosurg Clin N Am. 2019-7-10
World Neurosurg. 2017-3
Brain Sci. 2022-9-16
引用本文的文献
Front Endocrinol (Lausanne). 2022
J Neurol Surg B Skull Base. 2021-5-25
本文引用的文献
Neurosurg Clin N Am. 2015-7